Why sourcing add-on acquisitions can take years, why investment bankers carefully “coach” management teams, and other insights into the buy-and-build strategy from three experts.
Also on Privcap
- Robert van Zwieten, president and CEO of EMPEA, discusses what challenges LPs investing in emerging markets face, and why local LPs may have a leg up in some markets.
- McGladrey’s Tammy Hill tells Privcap what’s required of investments in healthcare data collection, and why some are leery of the privacy risks involved in gathering this kind of information.
- Guardian is seeking a partner to help with deal flow in co-investments.
How are GPs creating value in a disrupted, rapidly evolving market?
Privcap CEO David Snow interviewed J.C. Flowers & C. founder and managing director J. Christopher Flowers about the firm’s history, how the 2008 financial crisis affected the firm, and how to invest in financial services in these low-interest times.
An executive summary of the Privcap series exploring how GPs create value. In this briefing—produced in partnership with EY—you’ll find 10 case studies detailing how private equity improves portfolio companies.
Three experts discuss what non-U.S. GPs need to know before coming to the U.S. to fundraise.
The dramatic drop in oil prices is having a ripple effect across the economy, creating significant opportunities for middle-market private equity firms. John Breckenridge of Capital Dynamics and Joe Brusuelas of McGladrey discuss the winners and losers in the current environment, and the impact of the coming “tsunami” of capital.
India’s new government is pro-business, family-owned companies are welcoming investments, and exits are available. In this Privcap briefing based on a webinar discussion, three experts discuss how this translates into an opportunity for private equity.
A discussion of how GPs and LPs discuss fees associated with fund formation.